Related Experiment Video
Updated: Jun 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry
Michael J Greenberg1, Katarzyna Kazmierczak, Danuta Szczesna-Cordary
1Department of Physiology and Biophysics, Boston University School of Medicine, Boston, MA 02118, USA.
Insights
Familial hypertrophic cardiomyopathy (FHC) mutations in myosin regulatory light chain (RLC) reduce cardiac muscle force. These RLC mutations alter myosin
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Familial hypertrophic cardiomyopathy (FHC) is a genetic heart disease.
- Mutations in sarcomeric proteins, including myosin regulatory light chain (RLC), cause FHC.
- Two FHC-associated RLC mutations, R58Q and N47K, are located near the RLC's cationic binding site.
Purpose of the Study:
- To investigate the molecular mechanisms underlying FHC phenotypes caused by RLC mutations.
- To determine how RLC mutations affect myosin function and force generation.
Main Methods:
- Reconstituted porcine cardiac myosin with recombinant human wild-type (WT) or mutant RLC (R58Q, N47K).
- Assessed actin filament sliding velocity using the in vitro motility assay.
- Measured myosin force and power output under varying load conditions.
Main Results:
- Mutant RLC myosins showed reduced force and power output compared to WT or native myosin under load.
- Unloaded motility was similar between mutant and WT myosins.
- Mutation-induced alterations in loaded kinetics result from impaired myosin strain sensitivity of ADP affinity.
Conclusions:
- R58Q and N47K mutations in RLC alter myosin mechanical properties, specifically in the neck region.
- These alterations lead to abnormal load-dependent kinetics.
- The altered kinetics may explain the FHC phenotypes observed in patients with these mutations.
Abstract:
Familial hypertrophic cardiomyopathy (FHC) is caused by mutations in sarcomeric proteins including the myosin regulatory light chain (RLC). Two such FHC mutations, R58Q and N47K, located near the cationic binding site of the RLC, have been identified from population studies. To examine the molecular basis for the observed phenotypes, we exchanged endogenous RLC from native porcine cardiac myosin with recombinant human ventricular wild type (WT) or FHC mutant RLC and examined the ability of the reconstituted myosin to propel actin filament sliding using the in vitro motility assay. We find that, whereas the mutant myosins are indistinguishable from the controls (WT or native myosin) under unloaded conditions, both R58Q- and N47K-exchanged myosins show reductions in force and power output compared with WT or native myosin. We also show that the changes in loaded kinetics are a result of mutation-induced loss of myosin strain sensitivity of ADP affinity. We propose that the R58Q and N47K mutations alter the mechanical properties of the myosin neck region, leading to altered load-dependent kinetics that may explain the observed mutant-induced FHC phenotypes.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Overview of Myosin Structure and Function
Actin and Myosin in Muscle Contraction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cross-bridge Cycle
